Yale Jen
Stock Analyst at Laidlaw & Co.
(0.20)
# 4,486
Out of 5,182 analysts
16
Total ratings
12.5%
Success rate
-20.36%
Average return
Main Sectors:
Stocks Rated by Yale Jen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| KZIA Kazia Therapeutics | Initiates: Buy | $25 | $11.10 | +125.23% | 1 | Apr 15, 2026 | |
| PTN Palatin Technologies | Initiates: Buy | $60 | $22.50 | +166.67% | 1 | Dec 12, 2025 | |
| FEMY Femasys | Initiates: Buy | $6.5 | $0.42 | +1,433.38% | 1 | Nov 20, 2025 | |
| NSRX Nasus Pharma | Initiates: Buy | $22 | $2.24 | +882.14% | 1 | Sep 29, 2025 | |
| SNTI Senti Biosciences | Initiates: Buy | $5 | $1.10 | +354.55% | 1 | Jun 6, 2025 | |
| SLNO Soleno Therapeutics | Maintains: Buy | $75 → $105 | $52.78 | +98.94% | 2 | Mar 27, 2025 | |
| NVCT Nuvectis Pharma | Initiates: Buy | $19 | $8.90 | +113.48% | 1 | Mar 17, 2025 | |
| LFWD Lifeward | Initiates: Buy | $120 | $6.79 | +1,667.30% | 1 | Feb 10, 2025 | |
| ABVX ABIVAX Société Anonyme | Initiates: Buy | $48 | $120.16 | -60.05% | 1 | Jul 29, 2024 | |
| PHGE BiomX | Initiates: Buy | $475 | $1.84 | +25,715.22% | 1 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $225 | $1.44 | +15,525.00% | 1 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.45 | - | 2 | Dec 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.52 | +1,841.75% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.92 | - | 1 | Aug 15, 2023 |
Kazia Therapeutics
Apr 15, 2026
Initiates: Buy
Price Target: $25
Current: $11.10
Upside: +125.23%
Palatin Technologies
Dec 12, 2025
Initiates: Buy
Price Target: $60
Current: $22.50
Upside: +166.67%
Femasys
Nov 20, 2025
Initiates: Buy
Price Target: $6.5
Current: $0.42
Upside: +1,433.38%
Nasus Pharma
Sep 29, 2025
Initiates: Buy
Price Target: $22
Current: $2.24
Upside: +882.14%
Senti Biosciences
Jun 6, 2025
Initiates: Buy
Price Target: $5
Current: $1.10
Upside: +354.55%
Soleno Therapeutics
Mar 27, 2025
Maintains: Buy
Price Target: $75 → $105
Current: $52.78
Upside: +98.94%
Nuvectis Pharma
Mar 17, 2025
Initiates: Buy
Price Target: $19
Current: $8.90
Upside: +113.48%
Lifeward
Feb 10, 2025
Initiates: Buy
Price Target: $120
Current: $6.79
Upside: +1,667.30%
ABIVAX Société Anonyme
Jul 29, 2024
Initiates: Buy
Price Target: $48
Current: $120.16
Upside: -60.05%
BiomX
May 28, 2024
Initiates: Buy
Price Target: $475
Current: $1.84
Upside: +25,715.22%
Mar 18, 2024
Initiates: Buy
Price Target: $225
Current: $1.44
Upside: +15,525.00%
Dec 22, 2023
Downgrades: Hold
Price Target: n/a
Current: $5.45
Upside: -
Aug 28, 2023
Initiates: Buy
Price Target: $10
Current: $0.52
Upside: +1,841.75%
Aug 15, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.92
Upside: -